Neurocognitive Assessment And Rehabilitation Market Growth Accelerates: Strategic Forecast Predicts $21 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Neurocognitive Assessment And Rehabilitation Industry Market Size Be by 2025?
In recent times, the market size of the neurocognitive assessment and rehabilitation sector has experienced substantial growth. The market is projected to expand from $13.4 billion in 2024 to $14.7 billion in 2025, recording a compound annual growth rate (CAGR) of 9.7%. The surge in growth over the historic period can be ascribed to factors such as a rise in neurocognitive disorder cases, the aging population, heightened awareness and knowledge, healthcare policies and funding, enhanced diagnostic methods, and an upswing in mental health conditions.

What's the Long-Term Growth Forecast for the Neurocognitive Assessment And Rehabilitation Market Size Through 2029?
Expectations are high for the neurocognitive assessment and rehabilitation market to register robust growth in the coming years, expanding to a market size of $21 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. This expected growth during the projected period is mainly driven by factors including tailored healthcare solutions, corporate health initiatives, technological evolution, enhancements to insurance and reimbursement protocols, and the harmonization with telehealth. Key trends anticipated in the forecast period consist of the uptake of wearable tech, developments in regenerative medicine and neuroplasticity studies, customization of rehabilitation schemes, implementation of virtual and augmented reality, and a multidisciplinary approach.

View the full report here:
https://www.thebusinessresearchcompany.com/report/neurocognitive-assessment-and-rehabilitation-global-market-report

What Are the Key Growth Drivers Fueling the Neurocognitive Assessment And Rehabilitation Market Expansion?
The surge in the number of neurological disorders is anticipated to bolster the expansion of the neurocognitive assessment and rehabilitation market in the future. Neurological conditions are medical issues that impact the nervous system, including the brain, spinal cord, and nerves, resulting in symptoms such as muscle weakness, coordination difficulties, and cognitive deficits. These disorders can be ascribed to a mix of factors, particularly an aging population and the incidence of age-related diseases like Alzheimer's and Parkinson's. Neurocognitive evaluations furnish valuable details about cognitive abilities, assisting in the detection and medical planning for neurological conditions. Meanwhile, rehabilitation measures aim to maximize neural function and improve life quality through custom-made therapies and strategies. For example, as per the Alzheimer's Association, a voluntary health organization in the US, Alzheimer's dementia's prevalence, a neurological disorder, is expected to affect 2.4 million individuals aged 85 and above in the US by 2024, and this number is estimated to skyrocket to 6.7 million by 2060. Consequently, the rise in the prevalence of neurological disorders fuels the growth of the neurocognitive assessment and rehabilitation market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15870&type=smp

What Are the Key Trends Driving Neurocognitive Assessment And Rehabilitation Market Growth?
Leading firms in the neurocognitive assessment and rehabilitation market are pioneering innovative solutions such as digital screenings, to assess cognitive deficiencies and secure a competitive advantage. These digitally led tests utilize technological platforms or software for evaluating diverse cognitive capabilities including memory, attentiveness, linguistic skills, and executive functioning. For instance, Neurotrack Technologies, a US-established firm offering web-based checking tools and cognitive wellbeing programs, introduced a 3-minute digital test for screening cognitive impairment in November 2022. This instrument allows primary healthcare teams to quickly screen for cognitive degeneration during the annual wellness checks, facilitating the early recognition of neurodegenerative illnesses like Alzheimer's. It possesses features that are culturally-non-specific, improving accuracy and accessibility, and fulfilling the urgent need for cognitive screening in the graying population. These cutting-edge solutions allow healthcare providers to efficiently blend cognitive testing into clinical procedures, potentially transforming dementia care and intervention techniques.

How Is the Neurocognitive Assessment And Rehabilitation Market Segmented?
The neurocognitive assessment and rehabilitation market covered in this report is segmented -

1) By Components: Neurocognitive Assessment Testing, Neurorehabilitation Therapy
2) By Providers: Rehab Centers, Hospital And Clinics, Homecare Settings, Physiotherapy Centers
3) By Organization Size: Large Enterprises, Small And Medium-sized Enterprises (SMEs)

Subsegments:
1) By Neurocognitive Assessment Testing: Standardized Tests, Computerized Neurocognitive Assessments, Paper-Based Neurocognitive Tests
2) By Neurorehabilitation Therapy: Cognitive Behavioral Therapy (CBT), Virtual Reality Therapy, Transcranial Magnetic Stimulation (TMS), Neurofeedback Therapy, Physical Therapy And Occupational Therapy

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15870&type=smp

Which Companies Are Leading the Charge in Neurocognitive Assessment And Rehabilitation Market Innovation?
Major companies operating in the neurocognitive assessment and rehabilitation market are Cogstate Ltd., Posit Science Corporation, Lumos Labs Inc., The Magstim Company Ltd., MindMaze SA, CogniFit Inc., Cambridge Cognition Holdings plc, ImPACT Applications Inc., Neurotrack Technologies Inc., Neuroelectrics Corporation, SCHUHFRIED GmbH, Constant Therapy Health Inc., NeuronUP S.L., Qbtech AB, Neurometrix Inc., CogniVue Corporation, Neurohealth Associates LLP, BrainTrain Inc., NeuroEM Therapeutics Inc., HASOMED GmbH, Neurosoft Bioelectronics Corporation, AnthroTronix Inc., Flow Neuroscience AB, NPsych Limited

Which Regions Are Leading the Global Neurocognitive Assessment And Rehabilitation Market in Revenue?
North America was the largest region in the neurocognitive assessment and rehabilitation market in 2024. The regions covered in the neurocognitive assessment and rehabilitation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15870

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.